CHARLOTTE STEPHENSON: Open Payments
NPI 1770831174 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 79 payments from 30 companies in 2025. Trend: 2023 $843 · 2024 $1,520 · 2025 $1,602
Food & beverage: $1,423Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $200 |
| PFIZER INC. | 11 | $187 |
| ABBVIE INC. | 5 | $174 |
| Merck Sharp & Dohme LLC | 6 | $116 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| Celgene Corporation | 5 | $84 |
| Adaptive Biotechnologies Corporation | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Genentech USA, Inc. | 3 | $56 |
| Daiichi Sankyo Inc. | 2 | $49 |
Products named: VENCLEXTA, KEYTRUDA, DARZALEX, IBRANCE, REBLOZYL, clonoSEQ, Xtandi, ENHERTU.
Industry payments across IN — which companies pay providers there.
